Information Journal Paper
APA:
Copy. (2020). New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. ORAL ONCOLOGY, 106(-), 0-0. SID. https://sid.ir/paper/752715/en
Vancouver:
Copy. New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. ORAL ONCOLOGY[Internet]. 2020;106(-):0-0. Available from: https://sid.ir/paper/752715/en
IEEE:
Copy, “New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws,” ORAL ONCOLOGY, vol. 106, no. -, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/752715/en